Abstract
The recent debate started by David Healy [1]on the pages of this journal and further fueled by letters published in this issue [2, 3, 4]sparks again the decade-old debate ‘as to whether selective serotonin reuptake inhibitors (SSRIs) can trigger suicidality in vulnerable individuals’ [1]. The article by Healy [1]is carefully and elegantly written, and avoids definite statements, however the effect is, like in any good propaganda, that the reader may conclude that SSRIs at least increase the risk of suicide, if they do not outright cause it. The question for a careful and analyzing reader remains: Is that so? Is the evidence there?